tirzepatide microdosing online Instructions for Compounded Tirzepatide+ Microdosing Tirzepatide: An Innovative Approach

Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)

Wegovy (semaglutide) is prescribed for long-term weight management in individuals who are obese (with a body mass index of 30 or higher) or overweight (with a body mass index of 27 or higher) with at least one weight-related condition such as cardiovascular disease, high blood pressure, or type 2 diabetes

& Guichard, G

They also influence the circadian clock, the internal biological timer that determines when you feel awake and when you feel sleepy

She is dual board-certified in Internal Medicine and Obesity Medicine